$ZTS News

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth

Zoetis (ZTS) Slid on Weak Response to Great Ideas

Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know

UBS Maintains Neutral on Zoetis, Lowers Price Target to $85

Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong Fundamentals

Temporary Concerns Present Entry Point in Zoetis (ZTS)

Morgan Stanley Maintains Overweight on Zoetis, Lowers Price Target to $99

Zoetis (ZTS) Launches Two Long Acting Pet Pain Therapies In Canada And Europe

Zoetis Launches Portela® (relfovetmab) in Canada and the European Union

Zoetis Commercially Rolls Out Portela In Canada, EU To Treat Pain Associated With Osteoarthritis

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts

Zoetis Inc (NYSE:ZTS): A Top Value Stock with Undervalued Strength

Zoetis: An Attractive Risk-Reward Opportunity

Zoetis Earnings Preview: What to Expect

Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts

Zoetis to acquire medical imaging company in latest push to build AI

Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities

Zoetis Inks Agreement To Acquire Veterinary Teleradiology Services Platform VitalRADS; Financial Terms Undisclosed

Zoetis: Buy When There Is Blood In The Streets